Patents by Inventor Sanjeev A. Kulkarni

Sanjeev A. Kulkarni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9908880
    Abstract: Imidazoquinolines of formula I that contain substituted amine or amide functionality at 1-position and that are effective as Toll like Receptor 7 activators are disclosed. These compounds are useful as anticancer agents.
    Type: Grant
    Filed: September 19, 2016
    Date of Patent: March 6, 2018
    Assignee: 4SC AG
    Inventors: Volker Gekeler, Thomas Maier, Astrid Zimmermann, Hans-Peter Hofmann, Sanjeev A. Kulkarni, Anil P. Jagtap, Ganesh S. Chaure
  • Publication number: 20170029422
    Abstract: Imidazoquinolines of formula I that contain substituted amine or amide functionality at 1-position and that are effective as Toll like Receptor 7 activators are disclosed. These compounds are useful as anticancer agents.
    Type: Application
    Filed: September 19, 2016
    Publication date: February 2, 2017
    Applicant: 4SC AG
    Inventors: Volker GEKELER, Thomas MAIER, Astrid ZIMMERMANN, Hans-Peter HOFMANN, Sanjeev A. KULKARNI, Anil P. JAGTAP, Ganesh S. CHAURE
  • Patent number: 9446040
    Abstract: Imidazoquinolines of formula I that contain substituted amine or amide functionality at 1-position and that are effective as Toll like Receptor 7 activators are disclosed. These compounds are useful as anticancer agents.
    Type: Grant
    Filed: June 3, 2015
    Date of Patent: September 20, 2016
    Assignee: 4SC AG
    Inventors: Volker Gekeler, Thomas Maier, Astrid Zimmermann, Hans-Peter Hofmann, Sanjeev A. Kulkarni, Anil P. Jagtap, Ganesh S. Chaure
  • Publication number: 20150335636
    Abstract: Imidazoquinolines of formula I that contain substituted amine or amide functionality at 1-position and that are effective as Toll like Receptor 7 activators are disclosed. These compounds are useful as anticancer agents.
    Type: Application
    Filed: June 3, 2015
    Publication date: November 26, 2015
    Applicant: 4SC AG
    Inventors: Volker GEKELER, Thomas MAIER, Astrid ZIMMERMANN, Hans-Peter HOFMANN, Sanjeev A. KULKARNI, Anil P. JAGTAP, Ganesh S. CHAURE
  • Patent number: 9073913
    Abstract: Imidazoquinolines of formula I that contain substituted amine or amide functionality at 1-position and that are effective as Toll like Receptor 7 activators are disclosed. These compounds are useful as anticancer agents.
    Type: Grant
    Filed: March 23, 2009
    Date of Patent: July 7, 2015
    Assignee: 4SC AG
    Inventors: Volker Gekeler, Thomas Maier, Astrid Zimmermann, Hans-Peter Hofmann, Sanjeev A. Kulkarni, Anil P. Jagtap, Ganesh S. Chaure